Skip to main content
VCbacked
Log inGet Started

Glyphic Biotechnologies

New York, United States

Glyphic Biotechnologies is a biotechnology company that develops a protein sequencing platform.

$38.0M raised
Sep 2025
Series A
BiotechnologyHealth CareLife Science

Top Investors

GaingelsWing Venture CapitalCantosArtis VenturesQiagen

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Glyphic Biotechnologies

How much funding has Glyphic Biotechnologies raised?
Glyphic Biotechnologies has raised $38.0M in total funding. The most recent round was Series A. The last funding was announced in September 2025.
Who are Glyphic Biotechnologies's investors?
Glyphic Biotechnologies's investors include Gaingels, Wing Venture Capital, Cantos, Artis Ventures, Qiagen.
Where is Glyphic Biotechnologies headquartered?
Glyphic Biotechnologies is headquartered in New York, United States.
What does Glyphic Biotechnologies do?
Glyphic Biotechnologies is a biotechnology company that develops a protein sequencing platform.
What stage is Glyphic Biotechnologies at?
Glyphic Biotechnologies is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Glyphic Biotechnologies — Funding & Investors." VCBacked, September 26, 2025, https://www.vcbacked.co/company/glyphic-biotechnologies. Accessed June 3, 2026.
APA
VCBacked. (2025). Glyphic Biotechnologies — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/glyphic-biotechnologies
Wikipedia (cite web)
{{cite web |title=Glyphic Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/glyphic-biotechnologies |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong